Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHA+PQ vs ART+LUM vs AS+MQ for Uncomplicated Malaria in Cameroonian Children
NCT02974348Phase 3Completed
- Sponsor
- University of Bamenda
- Start
- Jan 2013
- Primary completion
- May 2013
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dihydroartemisinin + piperaquine in Malaria, sponsored by University of Bamenda. Started Jan 2013; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT02974348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02974348.